These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
373 related items for PubMed ID: 29600824
21. Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock. Menich BE, Miano TA, Patel GP, Hammond DA. Ann Pharmacother; 2019 Sep; 53(9):877-885. PubMed ID: 30957512 [Abstract] [Full Text] [Related]
22. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Russell JA, Walley KR, Gordon AC, Cooper DJ, Hébert PC, Singer J, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Dieter Ayers for the Vasopressin and Septic Shock Trial Investigators. Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882 [Abstract] [Full Text] [Related]
23. The Therapeutic Role of Vasopressin on Improving Lactate Clearance During and After Vasogenic Shock: Microcirculation, Is It The Black Box? Barzegar E, Ahmadi A, Mousavi S, Nouri M, Mojtahedzadeh M. Acta Med Iran; 2016 Jan; 54(1):15-23. PubMed ID: 26853286 [Abstract] [Full Text] [Related]
24. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study. Micek ST, Shah P, Hollands JM, Shah RA, Shannon WD, Kollef MH. Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364 [Abstract] [Full Text] [Related]
25. Septic shock--vasopressin, norepinephrine, and urgency. Parrillo JE. N Engl J Med; 2008 Feb 28; 358(9):954-6. PubMed ID: 18305271 [No Abstract] [Full Text] [Related]
26. Dynamic arterial elastance predicts mean arterial pressure decrease associated with decreasing norepinephrine dosage in septic shock. Guinot PG, Bernard E, Levrard M, Dupont H, Lorne E. Crit Care; 2015 Jan 19; 19(1):14. PubMed ID: 25598221 [Abstract] [Full Text] [Related]
27. A high mean arterial pressure target is associated with improved microcirculation in septic shock patients with previous hypertension: a prospective open label study. Xu JY, Ma SQ, Pan C, He HL, Cai SX, Hu SL, Liu AR, Liu L, Huang YZ, Guo FM, Yang Y, Qiu HB. Crit Care; 2015 Mar 30; 19(1):130. PubMed ID: 25887027 [Abstract] [Full Text] [Related]
28. Radial to femoral arterial blood pressure differences in septic shock patients receiving high-dose norepinephrine therapy. Kim WY, Jun JH, Huh JW, Hong SB, Lim CM, Koh Y. Shock; 2013 Dec 30; 40(6):527-31. PubMed ID: 24089010 [Abstract] [Full Text] [Related]
29. Low-dose vasopressin in the treatment of septic shock in sheep. Sun Q, Dimopoulos G, Nguyen DN, Tu Z, Nagy N, Hoang AD, Rogiers P, De Backer D, Vincent JL. Am J Respir Crit Care Med; 2003 Aug 15; 168(4):481-6. PubMed ID: 12791578 [Abstract] [Full Text] [Related]
30. The long-term survival rate of catecholamine-resistant septic shock in Japanese patients who received vasopressin therapy. Sawa N, Ubara Y, Katori H, Hoshino J, Suwabe T, Takemoto F, Uchida N, Masuoka K, Wake A, Taniguchi S, Takaichi K. Clin Nephrol; 2009 Aug 15; 72(2):129-36. PubMed ID: 19640370 [Abstract] [Full Text] [Related]
31. Comparative Effectiveness of Second Vasoactive Agents in Septic Shock Refractory to Norepinephrine. Nguyen HB, Lu S, Possagnoli I, Stokes P. J Intensive Care Med; 2017 Aug 15; 32(7):451-459. PubMed ID: 27189952 [Abstract] [Full Text] [Related]
32. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D'Egidio A, D'Ippoliti F, Raffone C, Venditti M, Guarracino F, Girardis M, Tritapepe L, Pietropaoli P, Mebazaa A, Singer M. JAMA; 2013 Oct 23; 310(16):1683-91. PubMed ID: 24108526 [Abstract] [Full Text] [Related]
33. Beneficial effects of short-term vasopressin infusion during severe septic shock. Patel BM, Chittock DR, Russell JA, Walley KR. Anesthesiology; 2002 Mar 23; 96(3):576-82. PubMed ID: 11873030 [Abstract] [Full Text] [Related]
34. Concomitant vasopressin and hydrocortisone therapy on short-term hemodynamic effects and vasopressor requirements in refractory septic shock. Buckley MS, MacLaren R. J Crit Care; 2017 Dec 23; 42():6-11. PubMed ID: 28647651 [Abstract] [Full Text] [Related]
35. Effects of Norepinephrine and Vasopressin Discontinuation Order in the Recovery Phase of Septic Shock: A Systematic Review and Individual Patient Data Meta-Analysis. Hammond DA, Sacha GL, Bissell BD, Musallam N, Altshuler D, Flannery AH, Lam SW, Bauer SR. Pharmacotherapy; 2019 May 23; 39(5):544-552. PubMed ID: 30893494 [Abstract] [Full Text] [Related]
36. Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study. Bauer SR, Aloi JJ, Ahrens CL, Yeh JY, Culver DA, Reddy AJ. J Crit Care; 2010 Jun 23; 25(2):362.e7-362.e11. PubMed ID: 19926252 [Abstract] [Full Text] [Related]
37. Effects of continuous vasopressin infusion in patients with septic shock. Obritsch MD, Jung R, Fish DN, MacLaren R. Ann Pharmacother; 2004 Jun 23; 38(7-8):1117-22. PubMed ID: 15178740 [Abstract] [Full Text] [Related]
38. Vasopressin in septic shock. Landry DW, Oliver JA. N Engl J Med; 2008 Jun 19; 358(25):2736-7; author reply 2737-8. PubMed ID: 18572443 [No Abstract] [Full Text] [Related]
39. Vasopressor Discontinuation Order in Septic Shock With Reduced Left Ventricular Function. Taylor A, Jones T, Forehand CC, Smith SE, Dykes H, Newsome AS. J Pharm Pract; 2022 Dec 19; 35(6):879-885. PubMed ID: 33977793 [Abstract] [Full Text] [Related]
40. Vasopressin in septic shock. Dünser MW, Hasibeder WR, Wenzel V. N Engl J Med; 2008 Jun 19; 358(25):2736; author reply 2737-8. PubMed ID: 18572442 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]